Clinical trials: Dialysis Catheter
Kidney Failure, Chronic, Catheter-Related Infections
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock solution, for prevention of central venous catheter associated bloodstream infection in hemodialysis patients.
- Trial name
- NCT02651428
- Testing
- Neutrolin, Heparin
- Where
- 5 sites in United States
- Volunteers
- 806 people
- Sponsor
- CorMedix Therapeutics
End Stage Renal Disease (ESRD)
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
The main objective of this research study was to compare the following outcomes between patients with a Hemodialysis Reliable Outflow (HeRO) Graft and patients with a cuffed catheter for dialysis access over one year: quality of…
- Trial name
- NCT01343251
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Merit Medical Systems, Inc.
Hemodialysis
Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters
This study aims to compare two available types of central venous haemodialysis catheters (lines) - CVCs, and will examine how easy they are to insert, complications, blood flow on dialysis over time, line loss, line clotting and…
- Trial name
- VyTes (NCT01022359)
- Testing
- TesioCath, LifeCath Twin
- Where
- United Kingdom
- Volunteers
- 80 people
- Sponsor
- Imperial College Healthcare NHS Trust
Chronic Kidney Disease
Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters
Numerous catheter designs have been studied to increase efficacy and minimize complications of catheter hemodialysis. Major complications of catheters include thrombosis, central venous stenosis, infection, and dialysis…
- Trial name
- NCT02796300
- Testing
- Bioflo Dialysis Catheter, Palindrome Dialysis Catheter
- Where
- United States
- Volunteers
- 32 people
- Sponsor
- University of California, Los Angeles
End-Stage Renal Disease
Cook Enforcer Post-Market Study
The purpose of this study is to evaluate the performance of the Cook Advance® Enforcer™ 35 Focal-Force PTA Balloon Catheter (or Enforcer balloon) in treating narrowed blood vessels compared to treatment with a conventional…
- Trial name
- NCT03552289
- Testing
- Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, Conventional angioplasty balloon catheters
- Where
- 5 sites in United States
- Volunteers
- 211 people
- Sponsor
- Cook Research Incorporated
End Stage Renal Failure on Dialysis
Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
This study will compare the use of tea tree oil as a topical nasal antiseptic to prevent infections in patients that need renal dialysis.
- Trial name
- NCT01214395
- Testing
- 5% tea tree oil nasal ointment
- Where
- Australia
- Volunteers
- 5 people
- Sponsor
- PathWest Laboratory Medicine WA
Infection; Dialysis Catheter
Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
Aim: To conduct a randomized, double-blinded, controlled phase II trial to investigate the use of a catheter lock solution consisting of N-acetylcysteine, tigecycline and heparin, in addition to systemic antibiotics, for the…
- Trial name
- NCT01483872
- Testing
- NAC/Tigecycline/Heparin combination lock solution, Standard anticoagulant (Heparin or Citrate)
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of California, San Diego
End Stage Renal Disease
Dialysis Catheter Comparative Clinical Trial
The purpose of this clinical trial is to compare the longevity of two dialysis catheters.
- Trial name
- NCT00526123
- Testing
- Symmetric Tip Catheter, Conventional Split-tip Catheter
- Where
- 14 sites in United States
- Volunteers
- 599 people
- Sponsor
- Tyco Healthcare Group
Renal Failure Chronic Requiring Hemodialysis, Chronic Renal Insufficiency
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
Randomized two-arm study examining 90 day primary patency of two FDA-approved tunneled dialysis catheters.
- Trial name
- TDC (NCT02685995)
- Testing
- VectorFlow TDC, Palindrome TDC
- Where
- 2 sites in United States
- Volunteers
- 100 people
- Sponsor
- University of Pennsylvania